Brief: Dms Group DMS Biotech Passes Phase 1 Of Instrument P.M.E Call For Proposals Of European Horizon 2020 Program

DIAGNOSTIC MEDICAL SYSTEMS SA

17/01/2019 17:52

Jan 17 (Reuters) - DIAGNOSTIC MEDICAL SYSTEMS SA  DMSP.PA :
    * DMS BIOTECH SUCCESSFULLY PASSES PHASE 1 OF THE INSTRUMENT
P.M.E
CALL FOR PROPOSALS OF THE EUROPEAN HORIZON 2020 PROGRAM AS PART
OF ITS RESEARCH INTO THE TREATMENT OF ERECTILE DYSFUNCTION
    * THIS FUNDING ALLOWS PHASE 2 PREPARATION TO BEGIN

Source text for Eikon:  urn:newsml:reuters.com:*:nACT56749
Further company coverage:  DMSP.PA 

 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))